A novel oncolytic HSV co-expressing IL-12 and anti-PD-1 for glioblastoma

被引：0
|
作者：
Ayele, Kalkidan [1 ]
Feng, Xiaodong [1 ]
Saha, Dipongkor [1 ]
机构：
[1] Calif Northstate Univ, Coll Pharm, Dept Pharmaceut & Biomed Sci, Elk Grove, CA 95757 USA
来源：
MOLECULAR THERAPY ONCOLOGY | 2024年 / 32卷 / 02期
关键词：
D O I：
10.1016/j.omton.2024.200810
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors
    Ji, Dongmei
    Weitao, Yao
    Tong, Xiangmin
    Zhang, Chenping
    Wang, Feng
    Chen, Zhendong
    Zhou, Yuhong
    Li, Zhendong
    Deng, Yaotiao
    Huang, Gang
    Tao, Zhiwei
    Zheng, Yulong
    Wang, Gang
    Liu, Guowen
    Chen, Jing
    Niu, Xiaohui
    Yang, Jilong
    Pang, Weijia
    Zhao, Min
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] ADJUNCTIVE THERAPY INCREASES EFFICACY OF M002, AN ONCOLYTIC HSV-1 EXPRESSING IL-12, IN PRECLINICAL MODELS OF NERVOUS SYSTEM TUMORS
    Bauer, David
    Harmon, Daniel
    Zheng, Xiaojia
    Meleth, Sreelatha
    Gillespie, G.
    Parker, Jackie
    Markert, James
    NEURO-ONCOLOGY, 2008, 10 (05) : 791 - 792
  • [23] Phase I Clinical Trial of M032, an IL-12 Expressing Oncolytic HSV-1, for Adult Patients With Recurrent Malignant Glioma
    Estevez-Ordonez, Dagoberto
    Stein, John
    Malekenia, Pedram
    Gallegos, Carlos
    Atchley, Travis
    Laskay, Nicholas M.
    Clements, Jennifer
    Leavenworth, Jianmei
    Riley, Kristen O.
    Lobbous, Mina
    Aban, Inmaculada
    Sorace, Ana
    Nabors, Burt
    Markert, James M.
    NEUROSURGERY, 2025, 71 : 70 - 70
  • [24] Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα (vol 18, pg 898, 2011)
    Choi, I-K
    Lee, J-S
    Zhang, S-N
    Park, J.
    Sonn, C. H.
    Lee, K-M
    Yun, C-O
    GENE THERAPY, 2011, 18 (09) : 942 - 942
  • [25] PD-1 INHIBITION CAN BE COMBINED WITH IL-12 IN SUBJECTS WITH RECURRENT GLIOBLASTOMA
    Chiocca, Ennio
    Lukas, Rimas
    Rao, Ganesh
    Buck, Jill
    Demars, Nathan
    Smith, Amy
    Miao, John
    Zhou, John
    Gelb, Arnold
    Cooper, Laurence
    NEURO-ONCOLOGY, 2019, 21 : 6 - 7
  • [26] Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12
    Guo, Zhi
    Gao, Hong-Yan
    Zhang, Tian-Yang
    Lou, Jin-Xing
    Yang, Kai
    Liu, Xiao-Dong
    He, Xue-Peng
    Chen, Hui-Ren
    BIOMEDICAL REPORTS, 2016, 5 (05) : 567 - 573
  • [27] Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma
    Nakashima, Hiroshi
    Tran Nguyen
    Kasai, Kazue
    Passaro, Carmela
    Ito, Hirotaka
    Goins, William F.
    Shaikh, Imran
    Erdelyi, Ronald
    Nishihara, Reiko
    Nakano, Ichiro
    Reardon, David A.
    Anderson, Ana C.
    Kuchroo, Vijay
    Chiocca, E. Antonio
    CLINICAL CANCER RESEARCH, 2018, 24 (11) : 2574 - 2584
  • [28] Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
    Mitchell, Dana
    Dey, Mahua
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S577 - S579
  • [29] A SINGLE SPARK CAN START A PRAIRIE FIRE - RETHINK THE COMBINATION STRATEGY AND CLINICAL SETTING OF IL-12 WITH ANTI-PD-1
    Tsou, Pei-Yi
    Lin, Wan-Ying
    Lee, Meng-Na
    Chen, San-Chi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1145 - A1145
  • [30] Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy
    Oh, Eonju
    Oh, Jung-Eun
    Hong, JinWoo
    Chung, YoonHo
    Lee, Yunki
    Park, Ki Dong
    Kim, Sungwan
    Yun, Chae-Ok
    JOURNAL OF CONTROLLED RELEASE, 2017, 259 : 115 - 127
12345